SE9102340D0 - Pharmaceutical composition containing carbachol and othercholinergic substances - Google Patents
Pharmaceutical composition containing carbachol and othercholinergic substancesInfo
- Publication number
- SE9102340D0 SE9102340D0 SE9102340A SE9102340A SE9102340D0 SE 9102340 D0 SE9102340 D0 SE 9102340D0 SE 9102340 A SE9102340 A SE 9102340A SE 9102340 A SE9102340 A SE 9102340A SE 9102340 D0 SE9102340 D0 SE 9102340D0
- Authority
- SE
- Sweden
- Prior art keywords
- substances
- othercholinergic
- pharmaceutical composition
- composition containing
- carbachol
- Prior art date
Links
- 229960004484 carbachol Drugs 0.000 title abstract 2
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
- 229960000910 bethanechol Drugs 0.000 abstract 1
- NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- HEDXEAAVEOJUCR-UHFFFAOYSA-N furtrethonium Chemical compound C[N+](C)(C)CC1=CC=CO1 HEDXEAAVEOJUCR-UHFFFAOYSA-N 0.000 abstract 1
- 229950008234 furtrethonium Drugs 0.000 abstract 1
- NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 abstract 1
- 229960002329 methacholine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9102340A SE9102340D0 (sv) | 1991-08-13 | 1991-08-13 | Pharmaceutical composition containing carbachol and othercholinergic substances |
| CA002114239A CA2114239C (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
| PCT/SE1992/000542 WO1993003718A1 (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
| AU24631/92A AU671805B2 (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
| ES92918041T ES2123005T3 (es) | 1991-08-13 | 1992-08-07 | Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas. |
| EP92850187A EP0528776A1 (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
| DE69227324T DE69227324T2 (de) | 1991-08-13 | 1992-08-07 | Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält |
| EP92918041A EP0661968B1 (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
| AT92918041T ATE172114T1 (de) | 1991-08-13 | 1992-08-07 | Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält |
| JP5504252A JPH06509801A (ja) | 1991-08-13 | 1992-08-07 | カルバコールおよびその他のコリン作動性物質を含有する薬学的組成物 |
| HU9400405A HU221592B (hu) | 1991-08-13 | 1992-08-07 | Eljárás száraz szem helyi kezelésére alkalmas, hatóanyagként karbakol-kloridot tartalmazó gyógyszerkészítmény előállítására |
| DK92918041T DK0661968T3 (da) | 1991-08-13 | 1992-08-07 | Farmaceutisk præparat indeholdende carbachol og andre cholinerge stoffer |
| NO940400A NO306447B1 (no) | 1991-08-13 | 1994-02-07 | Anvendelse av kolinerg substans for behandling av törre öyne |
| FI940637A FI108516B (sv) | 1991-08-13 | 1994-02-11 | Förfarande för framställning av ett farmaceutiskt preparat innehållande karbakolklorid |
| US08/326,797 US5679713A (en) | 1991-08-13 | 1994-10-20 | Pharmaceutical composition containing carbachol and other cholinergic substances |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9102340A SE9102340D0 (sv) | 1991-08-13 | 1991-08-13 | Pharmaceutical composition containing carbachol and othercholinergic substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9102340D0 true SE9102340D0 (sv) | 1991-08-13 |
Family
ID=20383456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9102340A SE9102340D0 (sv) | 1991-08-13 | 1991-08-13 | Pharmaceutical composition containing carbachol and othercholinergic substances |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5679713A (sv) |
| EP (2) | EP0528776A1 (sv) |
| JP (1) | JPH06509801A (sv) |
| AT (1) | ATE172114T1 (sv) |
| AU (1) | AU671805B2 (sv) |
| CA (1) | CA2114239C (sv) |
| DE (1) | DE69227324T2 (sv) |
| DK (1) | DK0661968T3 (sv) |
| ES (1) | ES2123005T3 (sv) |
| FI (1) | FI108516B (sv) |
| HU (1) | HU221592B (sv) |
| NO (1) | NO306447B1 (sv) |
| SE (1) | SE9102340D0 (sv) |
| WO (1) | WO1993003718A1 (sv) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2281755C (en) * | 1997-02-24 | 2006-11-07 | Michael Albert Kamm | Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| US6711436B1 (en) | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
| AU758370B2 (en) * | 1997-08-08 | 2003-03-20 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
| US6395758B1 (en) * | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| ES2443847T3 (es) | 2009-11-12 | 2014-02-20 | Acacia Pharma Limited | Uso de betanecol para el tratamiento de xerostomía |
| WO2016159351A1 (ja) * | 2015-04-03 | 2016-10-06 | 参天製薬株式会社 | 涙腺ドラッグデリバリーシステム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2185220A (en) * | 1938-08-17 | 1940-01-02 | Smith Kline French Lab | Medicinal agent |
| GB1386864A (en) * | 1972-02-11 | 1975-03-12 | Avicon Inc | Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications |
| EP0316345A1 (en) * | 1986-07-28 | 1989-05-24 | Liposome Technology, Inc. | Liposomes with enhanced retention on mucosal tissue |
| US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
-
1991
- 1991-08-13 SE SE9102340A patent/SE9102340D0/sv unknown
-
1992
- 1992-08-07 AU AU24631/92A patent/AU671805B2/en not_active Ceased
- 1992-08-07 JP JP5504252A patent/JPH06509801A/ja not_active Ceased
- 1992-08-07 EP EP92850187A patent/EP0528776A1/en active Pending
- 1992-08-07 DK DK92918041T patent/DK0661968T3/da active
- 1992-08-07 DE DE69227324T patent/DE69227324T2/de not_active Expired - Fee Related
- 1992-08-07 CA CA002114239A patent/CA2114239C/en not_active Expired - Fee Related
- 1992-08-07 HU HU9400405A patent/HU221592B/hu not_active IP Right Cessation
- 1992-08-07 AT AT92918041T patent/ATE172114T1/de not_active IP Right Cessation
- 1992-08-07 WO PCT/SE1992/000542 patent/WO1993003718A1/en not_active Ceased
- 1992-08-07 ES ES92918041T patent/ES2123005T3/es not_active Expired - Lifetime
- 1992-08-07 EP EP92918041A patent/EP0661968B1/en not_active Expired - Lifetime
-
1994
- 1994-02-07 NO NO940400A patent/NO306447B1/no unknown
- 1994-02-11 FI FI940637A patent/FI108516B/sv not_active IP Right Cessation
- 1994-10-20 US US08/326,797 patent/US5679713A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI940637A0 (sv) | 1994-02-11 |
| ATE172114T1 (de) | 1998-10-15 |
| NO940400L (no) | 1994-02-07 |
| EP0528776A1 (en) | 1993-02-24 |
| US5679713A (en) | 1997-10-21 |
| EP0661968A1 (en) | 1995-07-12 |
| HU221592B (hu) | 2002-11-28 |
| NO940400D0 (no) | 1994-02-07 |
| HUT65946A (en) | 1994-08-29 |
| HU9400405D0 (en) | 1994-05-30 |
| ES2123005T3 (es) | 1999-01-01 |
| EP0661968B1 (en) | 1998-10-14 |
| DE69227324D1 (de) | 1998-11-19 |
| CA2114239A1 (en) | 1993-02-14 |
| DK0661968T3 (da) | 1999-06-23 |
| NO306447B1 (no) | 1999-11-08 |
| WO1993003718A1 (en) | 1993-03-04 |
| JPH06509801A (ja) | 1994-11-02 |
| FI940637L (sv) | 1994-02-11 |
| DE69227324T2 (de) | 1999-04-29 |
| AU2463192A (en) | 1993-03-16 |
| CA2114239C (en) | 2003-10-21 |
| FI108516B (sv) | 2002-02-15 |
| AU671805B2 (en) | 1996-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL126038A0 (en) | Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them | |
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| ATE203019T1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane | |
| KR930012022A (ko) | 뇌조직 보호용 모다피닐(Modafinil) | |
| ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
| IL103459A0 (en) | Decahydroisoquinoline derivatives and pharmaceutical compositions containing them | |
| EP0765160A4 (sv) | ||
| ATE207342T1 (de) | Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen | |
| FI941771A0 (sv) | Effektiverat hudpenetreringssystem för förbättrad lokal administration av läkemedel | |
| DE69333775D1 (de) | Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten | |
| DE69531098D1 (de) | Piperidine und pyrrolidine | |
| BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
| DE69927584D1 (de) | Pharmazeutische zubereitungen zur behandlung von magengeschwüren | |
| FI940637A0 (sv) | Farmaceutisk komposition innehållande karbakol och andra kolinergiska substanser | |
| WO1996022305A3 (en) | Modified peptides | |
| NO934832D0 (no) | Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose | |
| AU6278680A (en) | Carbamates and pharmaceutical formulations containing them | |
| AU658197B2 (en) | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
| BR9813098A (pt) | Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào | |
| AU628492B2 (en) | Improvements in chemical compounds | |
| IL89015A (en) | Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation | |
| BG95724A (en) | Medicaments with analgetic, antiphlogestic and antibacterial effect for external use | |
| SE9203296D0 (sv) | The use of inositoltrisphate for the preparing of medicaments | |
| ITPD920102A0 (it) | Composizione farmaceutica utile per trattare malattie gastroenteriche,ferite e ustioni e come agente emostatico | |
| DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen |